PMCA2 mRNA was significantly elevated in specific breast cancers in both HER2 and Basal molecular subtypes, although within each subtype there was clear variation (Supplementary Fig. 1), this variance within Basal breast cancers may be the cause of the association between PMCA2 and survival in this subtype. Here, ATP2B2 is linked to breast cancer.